The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection
- 1 September 2013
- journal article
- Published by Elsevier in Kidney International
- Vol. 84 (3) , 468-481
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin productionNature Communications, 2011
- Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cellsCytokine, 2011
- Klotho deficiency is an early biomarker of renal ischemia–reperfusion injury and its replacement is protectiveKidney International, 2010
- Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca 2+ channel to maintain endothelial integrityProceedings of the National Academy of Sciences, 2010
- Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: Results of a double-blind, placebo-controlled, randomized trialAmerican Heart Journal, 2009
- Klotho is a substrate for α‐, β‐ and γ‐secretaseFEBS Letters, 2009
- Synergistic upregulation of erythropoietin receptor (EPO-R) expression by sense and antisense EPO-R transcripts in the canine lungProceedings of the National Academy of Sciences, 2008
- Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cellsBritish Journal of Cancer, 2008
- Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17Proceedings of the National Academy of Sciences, 2007
- Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promiseKidney International, 2006